WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
56.85
+0.49 (+0.87%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close56.36
Open56.44
Bid56.83 x 0
Ask56.84 x 0
Day's Range56.06 - 57.50
52 Week Range31.81 - 76.68
Volume1,729,672
Avg. Volume2,198,776
Market Cap19.584B
Beta (3Y Monthly)5.28
PE Ratio (TTM)N/A
EPS (TTM)-1.79
Earnings DateJun 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est76.00
  • Slack direct listing — What to know in markets Thursday
    Yahoo Finance5 hours ago

    Slack direct listing — What to know in markets Thursday

    Slack will finally make its public debut Thursday morning on the New York Stock Exchange under the ticker “WORK.”

  • Canopy Growth earnings: Can the world’s largest marijuana company keep growing like a weed?
    MarketWatch5 hours ago

    Canopy Growth earnings: Can the world’s largest marijuana company keep growing like a weed?

    After recreational marijuana sales were legalized last year, Canopy Growth Corp.’s pot sales jumped 360%. When the world’s largest pot company reports a fresher crop of results this week, that number may be less than 40%.

  • CNW Group6 hours ago

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO , June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (RIV.V) (CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019 . The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019 .

  • CNW Group8 hours ago

    Canopy Growth announces shareholder approval in connection with the proposed acquisition of Acreage & provides update on American hemp and CBD operations

    SMITHS FALLS, ON , June 19, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce that, at a special meeting of the Company's shareholders (the "Meeting") held earlier today, the Company's shareholders voted overwhelmingly in favour of the resolution (the "Canopy Shareholder Resolution") approving the issuance of common shares of Canopy Growth and certain amendments to certain outstanding Company warrants in connection with the Company's previously announced proposed acquisition (the "Transaction") of Acreage Holdings, Inc. ("Acreage").

  • Cannabis stocks higher as Canopy shareholders meet, CannTrust unveils California venture
    MarketWatch10 hours ago

    Cannabis stocks higher as Canopy shareholders meet, CannTrust unveils California venture

    Cannabis stocks were mostly higher Wednesday, as investors awaited the results of shareholder votes on Canopy Growth Corp.’s proposal to acquire Acreage Holdings Inc. with the companies hosting separate meetings that kick off at 10 a.m.

  • TheStreet.com11 hours ago

    Canopy Growth Rises Ahead of Shareholder Vote on Acreage Deal

    investors both approved the agreement that the former would acquire its U.S. counterpart for a total of $3.4 billion should cannabis achieve legality at the federal level . Shares of Canopy Growth were rising 0.7% to $42.35 ahead on Wednesday. Canopy isn't actually purchasing Acreage just yet, it's simply buying the rights to purchase the company as soon as cannabis is legalized on the federal level in the U.S.

  • Benzinga11 hours ago

    Bank Of America's Energy Drink Case Study: Early Distribution Deals Could Decide Winners In Cannabis Market

    The energy drink space may have a lesson for the budding cannabis industry, Bank of America Merrill Lynch says. While there was all kinds of buzz around energy drinks when Red Bull came along in 1997, ...

  • Canopy Growth Expands Its Product Offering, Adds Oral Thins
    Market Realist14 hours ago

    Canopy Growth Expands Its Product Offering, Adds Oral Thins

    On June 19, Canopy Growth (WEED) (CGC) and CURE Pharmaceutical announced a partnership to create a new CBD-based oral delivery thin film. The oral thins will be available for distribution globally.

  • Benzinga17 hours ago

    Canopy Growth, CURE Pharmaceutical To Work Together On CBD Oral Thin Films

    The companies will be working on a low-dose CBD oral thin film that will use CURE Pharmaceutical's patented CUREfilm technology. Canopy Growth will license the technology for global distribution. CUREfilm will offer Canopy Growth a dosage that is "ideal for administering cannabinoids," CURE said in a statement.

  • GlobeNewswire17 hours ago

    CURE Pharmaceutical and Canopy Growth to Produce CBD Oral Thin Films

    CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth Corporation (WEED.TO) (CGC), (“Canopy”) to develop a new low-dose cannabidiol (CBD) oral thin film (OTF) using CURE’s patented CUREfilm™ technology for global distribution. “This collaboration builds on our licensing agreement with Canopy and accelerates product commercialization,” said Rob Davidson, CEO of CURE Pharmaceutical. CURE is registered with the U.S. Drug Enforcement Agency (DEA) to develop and manufacture cannabis-derived and synthetic cannabinoid-based products using its CUREfilm technology at its facility in Oxnard, Calif. With CUREfilm, the delivery of cannabinoids is easier and more effective as it offers increased bioavailability, ease and precision of dosing and greater palatability.

  • Profit Projections Are Still Plunging for the 3 Most Popular Pot Stocks
    Motley Fool18 hours ago

    Profit Projections Are Still Plunging for the 3 Most Popular Pot Stocks

    Marijuana may not have investors seeing much green through 2020.

  • Barrons.com19 hours ago

    Marijuana Company Canopy Growth Group Reports Earnings Tomorrow. Here’s What to Expect.

    Canadian cannabis company Canopy Growth is scheduled to report fiscal fourth-quarter 2019 earnings on Thursday after the market closes.

  • Canopy Updates on Europe, Australia, and Africa
    Market Realist2 days ago

    Canopy Updates on Europe, Australia, and Africa

    Canopy Growth is making progress in the Australian market through its Spectrum Therapeutics brand, which caters to the demand for medical cannabis products. According to the company, the number of medical patients in the country has increased ten times in the last year.

  • What Would Legalization in New York State Mean for Cannabis?
    Market Realist2 days ago

    What Would Legalization in New York State Mean for Cannabis?

    New York has been on the fence about legalizing marijuana. In a series of tweets, New York City Mayor Bill De Blasio expressed strong support for legalizing cannabis the “RIGHT way.”

  • Canopy Growth Pens an Agreement with Procaps—Here Are the Details
    Market Realist2 days ago

    Canopy Growth Pens an Agreement with Procaps—Here Are the Details

    On June 18, Canopy Growth (WEED) (CGC) announced another international development: it has entered into an agreement with Procaps in Colombia. According to Canopy Growth, Procaps is active across the world, exporting its products to over 50 international markets.

  • Here's What's Behind June's Big Marijuana Stock Winner
    Motley Fool2 days ago

    Here's What's Behind June's Big Marijuana Stock Winner

    Look beyond the obvious picks to find an impressive performance.

  • Canopy Growth’s 4Q Earnings: Profitability Expectations
    Market Realist2 days ago

    Canopy Growth’s 4Q Earnings: Profitability Expectations

    On June 20, Canopy Growth (WEED) (CGC) is expected to report sales of 91.1 million Canadian dollars and a gross income of 24.4 million Canadian dollars. The company's margins are expected to compress.

  • Canopy Growth’s 4Q Earnings: What Can Investors Expect?
    Market Realist2 days ago

    Canopy Growth’s 4Q Earnings: What Can Investors Expect?

    On June 20, Canopy Growth (WEED) (CGC) is scheduled to announce its fourth-quarter and fiscal 2019 earnings after the market closes. The company's guidance will likely set the tone for the cannabis industry's near-term expectations.

  • Cannabis stocks mixed ahead of shareholder vote on Canopy/Acreage deal
    MarketWatch2 days ago

    Cannabis stocks mixed ahead of shareholder vote on Canopy/Acreage deal

    Cannabis stocks are mixed, with market leader Canopy Growth Corp. gaining after it announced its latest growth moves ahead of Wednesday’s shareholder vote on its proposal to acquire Acreage Holdings.

  • Benzinga3 days ago

    Canopy Growth Announces Colombian Manufacturing Agreement For Oil-Based Products

    Canopy said it will leverage Procaps’ encapsulation capacity. The Canopy subsidiary Spectrum Therapeutics has completed sales to patients in Chile and Brazil, the company said. In Australia, Spectrum received its first medical cannabis oil shipment in April, with sales commencing the following month.

  • Nasdaq Leads, Dow Jones Lags In Stock Market Rally; Lululemon Regains Entry
    Investor's Business Daily3 days ago

    Nasdaq Leads, Dow Jones Lags In Stock Market Rally; Lululemon Regains Entry

    The tech-heavy Nasdaq led the way early Monday. Top growth stock Lululemon is regaining a buy point in today's stock market action.

  • PR Newswire3 days ago

    Canopy Growth Provides Update on International Operations and Activities

    SMITHS FALLS, Ontario, June 17, 2019 /PRNewswire/ -- Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company's global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.

  • Benzinga3 days ago

    The Week Ahead In Cannabis: Canopy Earnings, CannaCon In Detroit And More

    Last week was quite eventful for the cannabis industry, with Colorado reaching $1.0 billion in sales and Kroger Co (NYSE: KR ) announcing plans to start carrying CBD products. Here’s what you should keep ...

  • Canopy Growth provides update on international operations and activities
    CNW Group3 days ago

    Canopy Growth provides update on international operations and activities

    SMITHS FALLS, ON , June 17, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company's global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.